about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Con...
Read More
18.31
-0.68
(-3.58%)
78,528
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..